Aspen Technology announces Board member Bob Whelan as Chair of the Board of Directors

– USA, MA –  Aspen Technology, Inc. (NASDAQ: AZPN), a global leader in industrial software, today announced the appointment of Bob Whelan as Chair of the Board of Directors, succeeding Jill Smith who resigned from the Board.

“I’m delighted to welcome Bob back to the position of Board Chair,” said Antonio Pietri, President and CEO of AspenTech. “Bob’s proven leadership and extensive knowledge of AspenTech make him well-suited for this role. I look forward to continuing to partner with him closely to deliver long-term shareholder value.”

About Robert Whelan, Jr.

Bob Whelan became a member of the Board in 2011 and previously served as Board Chair from 2013 to 2021. Throughout his tenure on the Board, Mr. Whelan has helped guide the company into an established industrial software leader, including the strategic transaction with Emerson Electric Co. Mr. Whelan also serves as a member of the Board’s Human Capital and M&A committees.

Bob Whelan is a Non-Emerson Director under the Stockholders Agreement by and among AspenTech, Emerson Electric Co., and EMR Worldwide Inc., dated as of May 16, 2022, previously filed with the Securities and Exchange Commission. Additionally, under the Stockholders Agreement, David Henshall, who served as a Non-Emerson Director following his appointment in April 2024, was re-designated as an Emerson Director on May 11, 2024. The Board intends to conduct a search over the coming months for a Non-Emerson Designee director under the Stockholders Agreement.

Robert Whelan, Jr. has over 35 years of corporate finance and investment banking experience. Since 2001, he has been President of Whelan & Company, LLC, providing financial consulting, valuation, and strategic services to public and private companies in the technology, healthcare, and alternative energy industries. From 1999 to 2001, Mr. Whelan served as Vice-Chairman, of Prudential Volpe Technology Group, the technology investment banking and research division of Prudential Securities formed when Prudential acquired Volpe Brown Whelan & Company in 1999. Before that, he was a senior executive with Volpe Brown Whelan, a private investment banking, brokerage, and asset management firm for technology and healthcare companies. Previously, he was Managing Director, of New York Regional and High Technology Groups at Prudential Securities, and Managing Director and Head of Corporate Finance at Hambrecht & Quist, Inc. Mr. Whelan served as a director for iAnthus Capital Holdings Inc. from 2019 to 2022, Annovis Bio, Inc. from 2016 to 2021, and ARIAD Pharmaceuticals, Inc. from 2010 to 2014, as well as other privately held companies.

“It’s an honor to return to the role of Board Chair for AspenTech,” said Bob Whelan. “On behalf of the Board, I’d like to thank Jill for her service over the years. She’s been a key advisor and trusted colleague through a pivotal time in the company’s transformation journey. We wish her the best in her future endeavors.”

Mr. Whelan received a B.A. in History from Dartmouth College and an M.B.A. from the Stanford University Graduate School of Business.

About Aspen Technology

Aspen Technology, Inc. is a global software leader helping industries at the forefront of the world’s dual challenge meet the increasing demand for resources from a rapidly growing population profitably and sustainably. AspenTech solutions address complex environments where it is critical to optimize the asset design, operation, and maintenance lifecycle. Through our unique combination of deep domain expertise and innovation, customers in capital-intensive industries can run their assets safer, greener, longer, and faster to improve their operational excellence.


- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.